Rose B. McGee

3.5k total citations
29 papers, 470 citations indexed

About

Rose B. McGee is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Rose B. McGee has authored 29 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Pediatrics, Perinatology and Child Health and 6 papers in Molecular Biology. Recurrent topics in Rose B. McGee's work include BRCA gene mutations in cancer (9 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Ethics and Legal Issues in Pediatric Healthcare (7 papers). Rose B. McGee is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Childhood Cancer Survivors' Quality of Life (9 papers) and Ethics and Legal Issues in Pediatric Healthcare (7 papers). Rose B. McGee collaborates with scholars based in United States, Canada and Australia. Rose B. McGee's co-authors include Harriet Druker, Katherine A. Schneider, Kim E. Nichols, Kami Wolfe Schneider, Sarah Scollon, William D. Foulkes, Kristin Zelley, Wendy Kohlmann, Laurence Brugières and Junne Kamihara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Clinical Cancer Research.

In The Last Decade

Rose B. McGee

26 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose B. McGee United States 9 192 138 120 81 77 29 470
Mary-Louise C. Greer Canada 5 93 0.5× 65 0.5× 128 1.1× 75 0.9× 56 0.7× 6 414
Zehra Ordulu United States 12 195 1.0× 91 0.7× 130 1.1× 46 0.6× 48 0.6× 36 559
A. H. J. T. Vriends Netherlands 15 130 0.7× 84 0.6× 113 0.9× 255 3.1× 82 1.1× 18 662
Cécile Verite France 16 26 0.1× 110 0.8× 144 1.2× 52 0.6× 109 1.4× 39 705
Donna Lancaster United Kingdom 10 32 0.2× 119 0.9× 67 0.6× 47 0.6× 49 0.6× 22 469
Yacov Goshen Israel 13 31 0.2× 51 0.4× 162 1.4× 65 0.8× 65 0.8× 18 443
Anna V. Hoekstra United States 17 42 0.2× 132 1.0× 106 0.9× 41 0.5× 33 0.4× 35 699
D. Bürger Germany 10 43 0.2× 105 0.8× 307 2.6× 71 0.9× 58 0.8× 19 649
Rossella Graffeo Switzerland 14 177 0.9× 30 0.2× 65 0.5× 157 1.9× 75 1.0× 31 549
Yoshinobu Moritoki Japan 12 96 0.5× 55 0.4× 272 2.3× 57 0.7× 12 0.2× 47 564

Countries citing papers authored by Rose B. McGee

Since Specialization
Citations

This map shows the geographic impact of Rose B. McGee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose B. McGee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose B. McGee more than expected).

Fields of papers citing papers by Rose B. McGee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose B. McGee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose B. McGee. The network helps show where Rose B. McGee may publish in the future.

Co-authorship network of co-authors of Rose B. McGee

This figure shows the co-authorship network connecting the top 25 collaborators of Rose B. McGee. A scholar is included among the top collaborators of Rose B. McGee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose B. McGee. Rose B. McGee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamihara, Junne, Jaclyn Schienda, Rose B. McGee, et al.. (2025). Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clinical Cancer Research. 31(9). 1573–1579. 1 indexed citations
2.
McGee, Rose B., et al.. (2025). Late-Onset Retinoblastoma. Ophthalmology Retina. 10(1). 95–101.
3.
Hsu, Chia‐Wei, Haitao Pan, Niki Jurbergs, et al.. (2025). The moderating role of parental cognitive perceptions in the link between children’s cancer predisposition genetic testing results and parent psychological adjustment. Journal of Pediatric Psychology. 51(3). 195–205.
4.
Maese, Luke, Marcin W. Włodarski, Alison A. Bertuch, et al.. (2024). Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy. Clinical Cancer Research. 30(19). 4286–4295. 3 indexed citations
5.
Hansford, Jordan R., Anirban Das, Rose B. McGee, et al.. (2024). Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors. Clinical Cancer Research. 30(11). 2342–2350. 9 indexed citations
6.
Harrison, Lynn, et al.. (2024). Playing Russian Roulette: Parent and Adolescent Perspectives on Tumor Surveillance for Adolescents with Cancer Predisposition Syndromes. Clinical Cancer Research. 30(17). 3845–3854. 1 indexed citations
7.
Zelley, Kristin, Jaclyn Schienda, Bailey Gallinger, et al.. (2024). Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance. Clinical Cancer Research. 30(18). 3983–3989. 5 indexed citations
8.
Sharp, Katianne M. Howard, M. Clark, Niki Jurbergs, et al.. (2024). A content analysis of parents’ reflections on pathogenic and uncertain pediatric oncology germline sequencing results. Familial Cancer. 23(4). 551–561. 1 indexed citations
9.
Morin, Cara E., Leslie M. Taylor, Rose B. McGee, et al.. (2024). Performance of Tumor Surveillance for Children With Cancer Predisposition. JAMA Oncology. 10(8). 1060–1060. 4 indexed citations
10.
Sharp, Katianne M. Howard, Chen Li, Zhaohua Lu, et al.. (2023). Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results. JCO Precision Oncology. 7(7). e2300159–e2300159. 6 indexed citations
11.
McGee, Rose B., Ninad Oak, Lynn Harrison, et al.. (2023). Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. Clinical Cancer Research. 29(7). 1243–1251. 9 indexed citations
12.
Sharp, Katianne M. Howard, et al.. (2023). Adolescent and Young Adult Understanding of Their Childhood Cancer Predisposition Diagnosis: A Qualitative Study. The Journal of Pediatrics. 261. 113538–113538. 2 indexed citations
13.
Mandrell, Belinda N., Katianne M. Howard Sharp, Jami S. Gattuso, et al.. (2023). Parental Understanding of Their Child’s Germline Genomic Testing: Intent of Disclosure to Their Child and Family. Journal of Personalized Medicine. 13(12). 1656–1656. 1 indexed citations
14.
Aronson, Melyssa, Chrystelle Colas, Andrew Y. Shuen, et al.. (2021). Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group. Journal of Medical Genetics. 59(4). 318–327. 57 indexed citations
15.
Johnson, Liza‐Marie, April Sykes, Zhaohua Lu, et al.. (2019). Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2‐visit consent model. Cancer. 125(14). 2455–2464. 26 indexed citations
16.
King, Benjamin, et al.. (2019). Unilateral retinoblastoma in a patient with Hermansky-Pudlak syndrome. Ophthalmic Genetics. 40(1). 83–85.
17.
Upadhyaya, Santhosh A., Rose B. McGee, Breelyn A. Wilky, & Alberto Broniscer. (2018). Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome. Pediatric Blood & Cancer. 65(7). e27030–e27030. 5 indexed citations
18.
Lucas, John T., Rose B. McGee, Catherine A. Billups, et al.. (2018). Prior non-irradiative focal therapies do not compromise the efficacy of delayed episcleral plaque brachytherapy in retinoblastoma. British Journal of Ophthalmology. 103(5). 699–703. 6 indexed citations
19.
Schultz, Kris Ann P., Surya P. Rednam, Junne Kamihara, et al.. (2017). PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clinical Cancer Research. 23(12). e76–e82. 109 indexed citations
20.
Davidson, Jesse T., Catherine G. Lam, Rose B. McGee, Armita Bahrami, & Alicia Diaz-Thomas. (2015). Parathyroid Cancer in the Pediatric Patient. Journal of Pediatric Hematology/Oncology. 38(1). 32–37. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary-Louise C. Greer Breakdown of academic impact, for papers by Zehra Ordulu Breakdown of academic impact, for papers by A. H. J. T. Vriends Breakdown of academic impact, for papers by Cécile Verite Breakdown of academic impact, for papers by Donna Lancaster Breakdown of academic impact, for papers by Yacov Goshen Breakdown of academic impact, for papers by Anna V. Hoekstra Breakdown of academic impact, for papers by D. Bürger Breakdown of academic impact, for papers by Rossella Graffeo Breakdown of academic impact, for papers by Yoshinobu Moritoki
Rankless by CCL
2026